Existing vaccines and booster shots against Covid are sufficient to prevent Omicron infections, said top infectious disease expert Dr Anthony Fauci, as he advised against changing the vaccines to fight the new, highly contagious strain of the virus at this time.
It has been known that Omicron evades efficacy from the current two-dose shots. A study from South Africa showed that protection from the two-dose vaccine against infection dropped to 33 per cent compared with 80 per cent before the emergence of Omicron.
However, two doses are still 70 per cent effective at preventing hospitalisation in Omicron patients in South Africa, Fauci told the public during a White House Covid update on Wednesday, the CNBC reported.
"Our booster vaccine regimens work against Omicron. At this point, there is no need for a variant-specific booster.
"Obviously, this is significantly down but there is the maintaining of a degree of protection against hospitalisation," Fauci said.
As a result, a booster dose has been advised by several countries. A booster dose increases protection against symptomatic disease to 75 per cent, Fauci said, citing data from the UK Health Security Agency, the report said.
"And so the message remains clear. If you are unvaccinated, get vaccinated, and particularly in the arena of Omicron if you are fully vaccinated, get your booster shot," he said.
The unvaccinated are eight times more likely to end up in the hospital and 14 times more likely to die compared with people who are fully vaccinated, said White House Covid response coordinator Jeff Zients, citing data from the US Centers for Disease Control and Prevention.
According to CDC Director Rochelle Walensky, 36 states in the US have detected Omicron so far, and the variant makes up about 3 per cent of Covid cases nationwide. However, Omicron infections are likely much higher in New York and New Jersey, she said, making up about 13 per cent of cases.
"Early data suggests that Omicron is more transmissible than delta with a doubling time of about two days," Walensky said.
Sixty-one per cent of Americans are fully vaccinated against Covid and 27 per cent of them have received a booster shot, according to CDC data.
About 68,000 Americans are hospitalised with Covid-19, according to a seven-day average of Department of Health and Human Services data as of Tuesday, up 9 per cent over the previous week and 21 per cent over the last two weeks.
A two-dose course of Pfizer and BioNTech SE’s
Covid-19 shot as well as a previous infection with the disease may give stronger protection against the Omicron variant, said scientists from the Africa Health Research Institute in South Africa. Blood plasma experiments led them to estimate there would be 73 per cent protection against symptomatic disease from Omicron and 95 per cent against severe infections for those who had been vaccinated and previously infected. (Bloomberg)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)